---
edited: 2024-03-02
tags:
---

| **Abbreviated Regimens**                             | **Options**                                                                                                   | **Indications**                                                                                                                                                      |
| ---------------------------------------------------- | ------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| BPaL or BPaLM                                        | Bedaquiline, pretomanid, and linezolid (BPaL) or bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) | Treatment of nonpregnant adults with uncomplicated pulmonary MDR-TB or XDR-TB, if susceptibility testing permits, in the absence of indications for a longer regimen |
| Other bedaquiline-containing regimens                | All-oral regimen containing bedaquiline and other antituberculous drugs                                       | Feasible when BPaL or BPaLM is not an option due to resistance or resource constraints                                                                               |
| Delamanid, linezolid, levofloxacin, and pyrazinamide | Delamanid, linezolid, levofloxacin, and pyrazinamide                                                          | Suitable alternative to a bedaquiline-based regimen                                                                                                                  |

| **Indications for Longer, Individualized Regimen**                                                                                                                                                                                                                                                                                                           | **Indications**                                                          |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ------------------------------------------------------------------------ |
| Disseminated, meningeal, CNS disease, or bone involvement                                                                                                                                                                                                                                                                                                    | Advanced HIV infection (CD4 <50 cells/microL) and extrapulmonary disease |
| Pregnancy                                                                                                                                                                                                                                                                                                                                                    | Extensive (or advanced) TB disease (e.g., bilateral cavitary disease)    |
| Contraindication to one or more drugs in the shorter course regimens, including: <br> - Prior exposure to drugs for more than one month (unless susceptibility confirmed) <br> - Confirmed resistance or suspected ineffectiveness to a drug <br> - Intolerance to a drug or risk of toxicity due to interactions <br> - Unavailability of one or more drugs |                                                                          |
ZE CELK and CEEL for longer time period
![[Pasted image 20240429110917.png]]
![[Pasted image 20240429125140.png]]
![[Pasted image 20240429125414.png]]


---
